使用含有纳米脂质体的海洋生物活性化合物制备功能补充剂粉末
Hadis Amiri1, Bahare Shabanpour1, Parastoo Pourashouri1
1Department of Fisheries, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran.
Journal of food science
|November 18, 2024
概括
纳米脂质体封装了海洋生物活性化合物,增强了它们在补充剂中的使用. 乳清蛋白缩涂层提高了溶解性和营养价值,克服了功能性食品的不稳定性和味道问题.
科学领域:
- 海洋生物技术 海洋生物技术
- 食品科学与技术 食品科学与技术
- 营养保健品 营养保健品
背景情况:
- 在补充剂和功能性食品中对海洋生物活性化合物的需求不断增长.
- 海洋化合物的挑战:不稳定性,苦味和消化系统退化.
- 需要有效的封装方法来提高生物可用性和应用.
研究的目的:
- 使用纳米脂质体封装开发一种功能补充剂粉末.
- 用于封装脂提取物,鱼油 (FO) 和鱼蛋白水解剂.
- 评估封装化合物的物理化学,营养,释放和感官特性.
主要方法:
- 纳米脂质体封装海洋生物活性化合物.
- 用单质/双质和复合形式的奇托和乳清蛋白缩物 (WPC) 涂覆纳米脂体.
- 72小时冷干燥,然后进行物理化学,营养,体外释放和感官分析.
主要成果:
- 用WPC单层处理显示出最高的溶解度 (28.83 mg/100 g) 和封装效率 (97.67%).
- 封装产品保留了大量的多不和脂肪酸 (PUFA),具有有利的氨基酸概况.
- 与胃酸状况相比,在肠道条件下观察到更高的化合物释放.
结论:
- 在脂肪体载体中封装是一种可行的策略,用于在功能性食品中利用海洋生物活性化合物.
- 用WPC涂层的纳米脂质体提供了更好的稳定性,可溶性和营养益处.
- 开发的补充剂粉末可以满足每日必需氨基酸和PUFAs的营养需求,当纳入牛奶等食品时.
相关概念视频
Bioavailability Enhancement: Drug Solubility Enhancement
455
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
455
Bioavailability Enhancement: Drug Permeability Enhancement
314
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
314


